We are live on
!
Find out more
ML
McAdam LLC Portfolio holdings
AUM
$2.22B
1-Year Est. Return
16.98%
This Fund
S&P 500
This Quarter
Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
(+13%)
Cap. Flow
+$24.9M
Cap. Flow
% of AUM
10.14%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202
Top Buys
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$2.75M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$2.47M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$2.28M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$2M |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.99M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$131K |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$113K |
| 3 |
Vanguard Growth ETF
VUG
|
+$104K |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$103K |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$97.9K |
Sector Composition
| 1 | Technology | 1.2% |
| 2 | Healthcare | 1.18% |
| 3 | Consumer Discretionary | 0.7% |
| 4 | Communication Services | 0.61% |
| 5 | Industrials | 0.6% |
Similar funds
VWM
NLGIA
IFA
DPCM
BOI
RAM
BHIA
WCMNY
McAdam LLC's Q2 2018 Portfolio in Review
As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.
By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.
- McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
- McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
- McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
- McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
- McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
- McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
- McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.
Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.